Hyperkalaemia as a cause of undertreatment with mineralocorticoid receptor antagonists in heart failure

Hyperkalaemia as a cause of undertreatment with mineralocorticoid receptor antagonists in heart failure

Abstract Aims To determine the incidence of hyperkalaemia in patients with heart failure with reduced ejection fraction (HFrEF) during up‐titration of guideline‐directed medical therapy (GDMT) in real‐world settings. Methods A retrospective review of medical records of all patients hospitalized for...

Full description

Bibliographic Details
Main Authors: Josefin Henrysson, Erik Thunström, Xiaojing Chen, Michael Fu, Carmen Basic
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:ESC Heart Failure
Subjects:
Hyperkalaemia
Heart failure
Epidemiology
Treatment
Mineralocorticoid receptor antagonists
Online Access:https://doi.org/10.1002/ehf2.14137

Similar Items

Similar Items